The US Food and Drug Administration warned nine online networks this week to stop illegally marketing “potentially dangerous, unapproved and misbranded” versions of opioid medications to the public. If these networks, which operate 53 websites, fail to comply, they risk enforcement action including product seizure or injunction.
Patients who purchase prescriptions from illegal online pharmacies risk purchasing counterfeit, contaminated, expired, or otherwise unsafe medications, according to the FDA.
“The FDA is taking additional steps to protect U.S. consumers from illicit opioids by targeting the websites that illegally market them and other illicit drugs. The internet is virtually awash in illegal narcotics and we’re going to be taking new steps to work with legitimate internet firms to voluntarily crack down on these sales” said FDA Commissioner Scott Gottlieb, M.D.
The FDA has given these companies ten days to inform them of the specific actions they’re taking to address concerns.